Dental impact of anti-fibroblast growth factor 23 therapy in X-linked hypophosphatemia

• Main Authors: Elis J. Lira dos Santos (Author), Kenta Nakajima (Author), Julien Po (Author), Ayako Hanai (Author), Volha Zhukouskaya (Author), Martin Biosse Duplan (Author), Agnès Linglart (Author), Takashi Shimada (Author), Catherine Chaussain (Author), Claire Bardet (Author)
• Format: Book
• Published: Nature Publishing Group, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Elevated fibroblast growth factor 23 (FGF23) in X-linked hypophosphatemia (XLH) results in rickets and phosphate wasting, manifesting by severe bone and dental abnormalities. Burosumab, a FGF23-neutralizing antibody, an alternative to conventional treatment (phosphorus and active vitamin D...